XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.91

-1.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (15879)	7/15/2002 10:08:26 PM
From: Cacaito	of 17367

Your Flumist example is perfect for Xanelim, incomplete data, clinicals, manufacturing, claims and batches sent back to square one. Either you are demented and do not remember your own jumps when after the Dermatology meetings you were sure they will be first to file and market, and later accusing Biogen of rushing and even the day by day clocking, to find out that Amevive is soon to be approved and market... while Xanelim is still in the figuring out state of looking to see if they can manufacture a working molecule in commercial amounts. Talking about fiction and contingency batches !!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next